Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial F1-ATPase is the soluble, catalytic sector of the bacterial ATP synthase. It is responsible for the synthesis and hydrolysis of adenosine triphosphate (ATP), a central molecule in cellular energy metabolism. The enzyme harnesses energy from a transmembrane electrochemical gradient to drive ATP production from adenosine diphosphate (ADP) and inorganic phosphate. It is a validated drug target for antibacterial treatment, but selectivity over mitochondrial homologs remains challenging. The F1 sector has subunit composition α3β3γδε.
Inhibition of ATP synthesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial F1-ATPase (F1-ATPase).